Extrawell Pharmaceutical Holdings Limited (HKG:0858)

HKG:0858 Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 23, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	122	72	160	208	373	215
Market Cap Growth	-32.65%	-55.22%	-22.99%	-44.23%	73.33%	-15.89%
Enterprise Value	-618	86	-551	157	309	123
Last Close Price	0.05	0.03	0.07	0.09	0.16	0.09
PE Ratio	0.78	-	1.24	1.59	-	2.58
Forward PE	-	45.63	45.63	45.63	45.63	45.63
PS Ratio	2.04	1.21	2.21	2.81	4.73	2.77
PB Ratio	0.10	0.06	0.13	0.18	0.36	0.19
P/TBV Ratio	0.10	0.07	0.13	0.18	0.36	0.19
P/FCF Ratio	75.80	-	-	-	-	-
P/OCF Ratio	43.38	-	135.70	-	-	-
EV/Sales Ratio	-	1.46	-	2.13	3.92	1.59
EV/EBITDA Ratio	-	117.59	-	-	-	-
EV/FCF Ratio	-384.53	-	-	-	-	-
Debt / Equity Ratio	0.11	0.11	0.08	0.07	0.07	0.06
Debt / EBITDA Ratio	55.37	48.34	-	-	-	-
Debt / FCF Ratio	80.96	-	-	-	-	-
Asset Turnover	0.05	0.04	0.05	0.06	0.07	0.06
Inventory Turnover	8.33	5.90	7.22	4.54	5.40	5.93
Quick Ratio	18.26	2.61	2.58	2.48	3.12	3.06
Current Ratio	18.71	3.45	3.13	3.03	3.65	3.59
Return on Equity (ROE)	15.67%	-13.50%	10.61%	11.95%	-11.03%	7.78%
Return on Assets (ROA)	-0.30%	-0.30%	-0.51%	-0.65%	-0.56%	-0.41%
Return on Capital (ROIC)	-0.31%	-0.31%	-0.53%	-0.69%	-0.59%	-0.44%
Earnings Yield	144.15%	-227.27%	80.73%	62.80%	-32.48%	38.72%
FCF Yield	1.32%	-6.82%	-3.40%	-5.48%	-0.42%	-6.24%
Buyback Yield / Dilution	-18.83%	27.36%	-	-37.66%	27.36%	-

Updated Dec 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.